Product Information
CATHFLO ACTIVASE 2 MG VIAL is a brand product labeled by Genentech, Inc., priced at $186.3796 per EA under NDC 50242004164. Its NADAC has been published 380 times since Nov 28, 2013.
Strength
2.2 mg/2mL
Manufacturer
Genentech, Inc.NDC
50242004164
Classification
Brand
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Effective Date
1/1/2026
Active Ingredients
ALTEPLASEApproval Type
Biologic (BLA)
FDA Application
BLA103172On Market Since
9/4/2001
Price Statistics
The NADAC for CATHFLO ACTIVASE 2 MG VIAL has been published 380 times since Nov 28, 2013, and over the history we have for it it has risen 79.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $186.3796 per EA |
|---|---|
| All-time high | $186.3796 (Sep 30, 2026) |
| All-time low | $103.8780 (Nov 28, 2013) |
| 52-week high | $186.3796 |
| 52-week low | $177.5027 |
| Median price | $142.1451 |
| Average price | $143.3457 |
| Largest weekly change | +14.7% (Aug 21, 2024) |
| Weeks tracked | 380 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Alteplase market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Genentech, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Alteplase market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CATHFLO ACTIVASE 2 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for CATHFLO ACTIVASE 2 MG VIAL, manufactured by Genentech, Inc., is $186.3796 per EA (NDC 50242004164), effective Sep 30, 2026.
How has the price of CATHFLO ACTIVASE 2 MG VIAL changed over time?
Over the history we have for it, the NADAC for CATHFLO ACTIVASE 2 MG VIAL has risen 79.4%. It has been tracked across 380 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CATHFLO ACTIVASE 2 MG VIAL?
Since Nov 28, 2013, the NADAC for CATHFLO ACTIVASE 2 MG VIAL has ranged from a low of $103.8780 (Nov 28, 2013) to a high of $186.3796 (Sep 30, 2026), with a median of $142.1451 per EA.
Are there cheaper alternatives to CATHFLO ACTIVASE 2 MG VIAL?
No other NADAC-published product currently shares the active ingredient and strength of CATHFLO ACTIVASE 2 MG VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CATHFLO ACTIVASE 2 MG VIAL?
CATHFLO ACTIVASE 2 MG VIAL (NDC 50242004164) is labeled by Genentech, Inc., and CMS classifies it as a brand product.